Abstract
Polymorphism of two tumor-suppressor genes, BRCA1 and P53, was examined. DNA was extracted from blood leukocytes of the women affected with breast cancer (N = 151) and of the women with no clinical symptoms of tumor diseases (N = 191). Typing of the polymorphic variants was performed using PCR-RFLP method. It was demonstrated that the genetic structure of the patient group (taking into consideration BRCA1 and P53 polymorphic variants) differed from that of the control group. The group of genotypes, found exclusively among the patients, as well as the group of “ resistant” genotypes revealed predominantly among the controls, was described. Detection of the genotype A 1 A 1 B 1 B 1 S 1 S 1 C 1 C 1 F 1 F 1 J 2 J 2, whose frequency in control group was eight times higher than in the patient group, was an additional confirmation of the existence of “resistant” genotypes. These findings point to the association between the combinations of the BRCA1 and P53 allelic variants and the risk of breast cancer.
Similar content being viewed by others
REFERENCES
Castilla, L.H., Couch, F.J., Erdos, M.R., et al., Mutations in the BRCA1 Gene in Families with Early-Onset Breast and Ovarian Cancer, Nat. Genet., 1994, vol. 8, pp. 387–391.
Smith, S.A., Easton, D.F., Evans, D.G.R., and Ponder, B.A.J., Allele Losses in the Region 17q12-21 in Familial Breast and Ovarian Cancer Involve the Wild-Type Chromosome, Nat. Genet., 1992, vol. 2, pp. 128–131.
Kelsell, D.P., Black, D.M., Bishop, D.T., and Spurr, N.K., Genetic Analysis of the BRCA1 Region in a Large Breast/Ovarian Family: Refinement of the Minimal Region Containing BRCA1, Hum. Mol. Genet., 1993, vol. 2, pp. 1823–1828.
Friedman, L.S., Ostermeyer, E.A., Szabo, C.I., et al., Confirmation of BRCA1 by Analysis of Germline Mutations Linked to Breast and Ovarian Cancer in Ten Families, Nat. Genet., 1994, vol. 8, pp. 399–404.
Miki, Y., Swensen, J., Shattuck-Eidens, D., et al., A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1, Science, 1994, vol. 266, pp. 66–71.
Easton, D.F., Steele, L., Fields, P., et al., Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12-13, Am. J. Hum. Genet., 1997, vol. 61, pp. 120–128.
Friedman, L.S., Szabo, C.I., Ostermeyer, E.A., et al., Novel Inherited Mutations and Variable Expressivity of BRCA1 Alleles, Including the Founder Mutation 185delAG in Ashkenazi Jewish Families, Am. J. Hum. Genet., 1995, vol. 57, pp. 1284–1297.
Struewing, J.P., Hartge, P., Wacholder, S., et al., The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews, New Eng. J. Med., 1997, vol. 336, pp. 1401–1408.
Szabo, C.I. and King, M.-C., Population Genetics of BRCA1 and BRCA2, Am. J. Hum. Genet., 1997, vol. 60, pp. 1013–1020.
Gorski, B., Byrski, T., Huzarski, T., et al., Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer, Am. J. Hum. Genet., 2000, vol. 66, pp. 1963–1968.
Arason, A., Barkardottir, R.B., and Egilsson, V., Linkage Analysis of Chromosome 17q Markers and Breast-Ovarian Cancer in Icelandic Families, and Possible Relationship to Prostatic Cancer, Am. J. Hum. Genet., 1993, vol. 52, pp. 711–717.
Schorge, J.O., Muto, M.G., Welch, W.R., et al., Molecular Evidence for Multifocal Papillary Serous Carcinoma of the Peritoneum in Patients with Germline BRCA1 Mutations, J. Natl. Cancer Inst., 1998, vol. 90, pp. 841–845.
Couch, F.J. and Weber, B.L., Mutations and Polymorphisms in the Familial Early-Onset Breast Cancer (BRCA1) Gene, Hum. Mutat., 1996, vol. 8, pp. 8–18.
Welsh, P.L. and Owens, K.N., Insights into the Functions of BRCA1 and BRCA2, Trends Genet., 2000, vol. 16, pp. 69–74.
Brzovic, P.S. and Rajafopal, P., Structure of a BRCA1-BARD1 Heterodimeric RINF-RING Complex, Nat. Struct. Biol., 2001, vol. 8, pp. 833–837.
Wang, Y., Cortez, D., Yazdi, P., et al., BASC, a Super Complex of BRCA1-Associated Proteins Involved in the Recognition and Repair of Aberrant DNA Structures, Genes Dev., 2000, vol. 14, pp. 927–939.
Tarasov, V.A., Aslanyan, M.M., Tsyrendorzhieva, E.S., et al., Genotype Dependence of the Risk of Breast Cancer in Women, Dokl. Akad. Nauk, 2004, vol. 398, no.2, pp. 282–285.
Altukhov, Yu.P., Kurbatova, O.L., Botvin’ev, O.K., et al., Gene Markers and Diseases: Genetic, Anthropometric, and Clinical Features of Children with Acute Pneumonia, Genetika (Moscow), 1981, vol. 17, no.5, pp. 920–931.
Altukhov, Yu.P. and Dubrova, Yu.E., Frequency of Rare Electrophoretic Variants of Proteins in Human Spontaneous Abortions, Dokl. Akad. Nauk SSSR, 1982, vol. 262, no.4, pp. 982–985.
Altukhov, Yu.P. and Kurbatova, O.L., Problem of Adaptive Norm in Human Populations, Genetika (Moscow), 1990, vol. 26, no.4, pp. 583–598.
Baranov, V.S., Genetic Basis of Predisposition to Some Common Multifactorial Diseases, Med. Genet., 2004, vol. 3, no.3, pp. 102–112.
Wolff, M.S. and Weston, A., Breast Cancer Risk and Environmental Exposures, Environ. Health Perspect., 1997, vol. 105, no.4, pp. 891–896.
Vogelstein, B. and Kinzler, K.W., The Multistep Nature of Cancer, Trends Genet., 1993, vol. 9, pp. 138–141.
Kiselev, F.L., DNA Stability Genes and Carcinogenesis, Mol. Biol. (Moscow), 1998, vol. 32, no.2, pp. 197–205.
Madigan, M.P. and Ziegler, R.G., Proportion of Breast Cancer Cases in the United States Explained by Well-Established Risk Factors, J. Natl. Cancer Inst., 1995, vol. 87, pp. 1681–1895.
Gowen, L.C., Avrutskaya, A.V., Latour, A.M., et al., BRCA1 Required for Transcription-Coupled Repair of Oxidative DNA Damage, Science, 1998, vol. 281, pp. 1009–1012.
Gowen, L.C., Avrutskaya, A.V., Latour, A.M., et al., Retraction (Letter), Science, 2003, vol. 300, p. 1657.
Fan, S., Wang, J.-A., Yuan, R., et al., BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells, Science, 1999, vol. 284, pp. 1354–1356.
Bochar, D.A., Wang, L., Beniya, H., et al., BRCA1 Is Associated with a Human SWI/SNF-Related Complex: Linking Chromatin Remodeling to Breast Cancer, Cell (Cambridge, Mass.), 2000, vol. 102, pp. 257–265.
Yarden, R.I., Pardo-Reoyo, S., Sgagias, M., et al., BRCA1 Regulates the G2/M Checkpoint by Activating Chk1 Kinase upon DNA Damage, Nat. Genet., 2002, vol. 30, pp. 265–269.
Hakem, R. and Mak, T.W., Animal Models of Tumor-Suppressor Genes, Annu. Rev. Genet., 2001, vol. 35, pp. 209–241.
Gowen, L.C., Johnson, B.L., Latour, A.M., et al., Brca1 Deficiency Results in Early Embryonic Lethality Characterized by Neuroepithelial Abnormalities, Nat. Genet., 1996, vol. 12, pp. 191–194.
Shen, S.X., Weaver, Z., Xu, X., et al., A Targeted Disruption of the Murine BRCA1 Gene Causes γ-Irradiation Hypersensitivity and Genetic Instability, Oncogene, 1998, vol. 17, pp. 3115–3124.
Xu, X., Wagner, K.U., Larson, D., et al., Conditional Mutation of BRCA1 in Mammary Epithelial Cells Results in Blunted Ductal Morphogenesis and Tumor Formation, Nat. Genet., 1999, vol. 22, pp. 37–43.
Armitage, P. and Doll, R., The Age Distribution of Cancer and Multi-Stage Theory of Carcinogenesis, Br. J. Cancer, 1954, vol. 8, pp. 1–12.
Schuyer, M. and Berns, E.M., Is TP53 Dysfunction Required for BRCA1-Associated Carcinogenesis?, Mol. Cell. Endocrinol., 1999, vol. 155, pp. 143–152.
Author information
Authors and Affiliations
Additional information
__________
Translated from Genetika, Vol. 41, No. 8, 2005, pp. 1115–1124.
Original Russian Text Copyright © 2005 by Tarasov, Aslanyan, Tsyrendorzhiyeva, Garkavtseva, Lyubchenko, Altukhov, Mel’nik.
Rights and permissions
About this article
Cite this article
Tarasov, V.A., Aslanyan, M.M., Tsyrendorzhiyeva, E.S. et al. Population Genetic Analysis of the Association Between the BRCA1 and P53 Gene Polymorphisms and the Risk of Sporadic Breast Cancer. Russ J Genet 41, 913–921 (2005). https://doi.org/10.1007/s11177-005-0180-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11177-005-0180-z